Compare LUNG & RGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LUNG | RGT |
|---|---|---|
| Founded | 1995 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.1M | 94.4M |
| IPO Year | 2020 | N/A |
| Metric | LUNG | RGT |
|---|---|---|
| Price | $1.96 | $14.42 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $5.38 | N/A |
| AVG Volume (30 Days) | ★ 342.0K | 20.6K |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.43% |
| EPS Growth | ★ 7.64 | N/A |
| EPS | N/A | ★ 0.92 |
| Revenue | ★ $90,497,000.00 | N/A |
| Revenue This Year | $2.48 | N/A |
| Revenue Next Year | $18.46 | N/A |
| P/E Ratio | ★ N/A | $15.52 |
| Revenue Growth | ★ 8.01 | N/A |
| 52 Week Low | $1.13 | $12.01 |
| 52 Week High | $2.89 | $15.79 |
| Indicator | LUNG | RGT |
|---|---|---|
| Relative Strength Index (RSI) | 42.05 | 27.58 |
| Support Level | $1.20 | $13.97 |
| Resistance Level | $2.16 | $14.85 |
| Average True Range (ATR) | 0.15 | 0.30 |
| MACD | -0.08 | -0.13 |
| Stochastic Oscillator | 12.26 | 5.63 |
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.
Royce Global Value Trust Inc is a diversified closed-end investment company. The Fund spreads its investments across diversified sectors such as information technology, consumer discretionary, health care, materials, consumer staples and energy. Geographically, it has presence in the United Kingdom, Japan, the United States, Canada, France, Hong Kong and Germany.